In the Journals

Volatile organic compounds in breath show promise as biomarkers for IBS

May 13, 2016
Researchers have identified a set of 16 volatile organic compounds in the breath that together may serve as biomarkers with potential utility in the…

Meeting News CoverageVideo

VIDEO: Expert highlights noninvasive testing for IBD and IBS, other gastroenterology updates

May 11, 2016
WASHINGTON — John I. Allen, MD, MBA, clinical chief of digestive diseases at Yale University School of Medicine, highlighted six recently…

In the Journals

No increased prevalence of microscopic colitis found in patients with IBS symptoms

April 28, 2016
Although a third of patients with microscopic colitis experienced symptoms that overlap with irritable bowel syndrome, researchers did not observe…

In the Journals

Ibodutant improves IBS-D symptoms in women

April 22, 2016
Ibodutant, a selective neurokinin-2 receptor antagonist, significantly improved overall symptoms, abdominal pain and stool pattern in women with…

Meeting News Coverage

Migraine may increase risk for IBS in patients without comorbid mood disorders

April 18, 2016
Migraine was a risk factor for future development of irritable bowel syndrome in patients who do not have comorbid mood disorders, but not in…

AGA survey results highlight physical, emotional burden of IBS

April 14, 2016
The American Gastroenterological Association has announced that a new analysis of data from its IBS in America survey reveals new information about…

10 news highlights to mark IBS Awareness Month

April 8, 2016
April is Irritable Bowel Syndrome Awareness Month, first designated by the International Foundation for Functional Gastrointestinal Disorders in…

In the Journals

Depression, somatization linked to postprandial symptoms in IBS patients

April 6, 2016
Psychosocial morbidities are linked to higher levels of gastrointestinal symptoms in patients with irritable bowel syndrome, and specifically…

Cover Story

Low FODMAPs Diet in IBS: Experts Disagree on Evidence of Efficacy

Healio Gastroenterology, March 2016
Interest in dietary interventions for irritable bowel syndrome has seen a recent revival, prompted by randomized controlled trial data suggesting…

Editorial

The Diet Debate in IBS

Healio Gastroenterology, March 2016
A revitalized interest in dietary therapies for irritable bowel syndrome is marked by accumulating data presented in the journals and at leading…

In the Journals

Low FODMAP diet may significantly improve IBS symptoms

March 25, 2016
Researchers observed that dietary fermentable oligosaccharides, disaccharides and monosaccharides and polyols — or FODMAPs — were linked…

In the Journals

Global IBS prevalence among adults difficult to determine

February 24, 2016
Data from a literature review demonstrate that despite the numerous studies performed worldwide to ascertain irritable bowel syndrome prevalence…

Migraine, tension headaches may be genetically linked to IBS

February 24, 2016
Migraine and tension headaches may have genetic links in common with irritable bowel syndrome, according to results from a preliminary study released…

In the Journals

Lactulose challenge test may help determine IBS severity

February 11, 2016
Visceral sensitivity and severity of irritable bowel syndrome may be determined with the use of a nutrient and lactulose challenge test. The results…

ExeGi launches Visbiome probiotic

February 4, 2016
ExeGi Pharma has launched Visbiome and Visbiome Extra Strength, new probiotic formulations comparable to VSL#3 that relieve symptoms associated with…

In the Journals

Comprehensive self-management program benefits IBS patients

January 28, 2016
A comprehensive self-management program designed to improve quality of life and reduce symptoms in patients with irritable bowel syndrome resulted in…

In the Journals

Viberzi improves symptoms of IBS-D

January 20, 2016
Viberzi safely and effectively reduced symptoms of irritable bowel syndrome with diarrhea, according to the results of two phase 3 trials…

Microbiome-based therapy meets primary endpoint in phase 2 trial of patients with IBS-C

January 20, 2016
SYN-010, a microbiome-based therapy in development for patients with irritable bowel syndrome with constipation, significantly reduced methane…

In the Journals

Ebastine reduces symptoms in patients with IBS

January 18, 2016
Ebastine, a histamine receptor H1 antagonist, was found to reduce visceral hypersensitivity, symptoms and abdominal pain in patients with irritable…

In the Journals

Patients with IBS-D benefit from gluten-free diet

January 14, 2016
A dietitian-directed gluten-free diet was found to be beneficial for patients with irritable bowel syndrome with diarrhea when studied in patients…